Authors:
BERTINI M
FREILONE R
BOTTO B
CALVI R
GALLAMINI A
GATTI AM
LIBERATI AM
MENEGHINI V
ORLANDI E
ORSUCCI L
PIZZUTI M
SCALABRINI DR
SALVI F
TODESCHINI G
VITOLO U
RESEGOTTI L
Citation: M. Bertini et al., IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN), Haematologica, 82(3), 1997, pp. 309-313
Authors:
FREILONE R
BOTTO B
VITOLO U
BERTINI M
AUDISIO E
CALVI R
CUCCHI M
DECRESCENZO A
GALLAMINI A
GHIO R
GRISO L
LEVIS A
MASSARA G
ORSUCCI L
RICARDI U
SCALABRINI DR
SALVI F
SECONDO V
RESEGOTTI L
Citation: R. Freilone et al., COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 919-924
Authors:
LEVIS A
DEPAOLI L
BERTINI M
BOTTO B
CIRAVEGNA G
FREILONE R
GALLAMINI A
GAVAROTTI P
RICARDI U
SCALABRINI DR
SALOMONE A
SALVI F
VITOLO U
PILERI A
SANNAZZARI GL
RESEGOTTI L
Citation: A. Levis et al., RESULTS OF A LOW AGGRESSIVITY CHEMOTHERAPY REGIMEN (CVP CEB) IN ELDERLY HODGKINS-DISEASE PATIENTS/, Haematologica, 81(5), 1996, pp. 450-456
Authors:
BERTINI M
FREILONE R
VITOLO U
BOTTO B
PIZZUTI M
GAVAROTTI P
LEVIS A
ORLANDI E
ORSUCCI L
PINI M
SCALABRINI DR
SALVI F
SECONDO V
TODESCHINI G
VIERO P
VOLTA C
RESEGOTTI L
Citation: M. Bertini et al., P-VEBEC - A NEW 8-WEEKLY SCHEDULE WITH OR WITHOUT RG-CSF FOR ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Annals of oncology, 5(10), 1994, pp. 895-900
Authors:
LEVIS A
DEPAOLI L
URGESI A
BERTINI M
ORSUCCI L
VITOLO U
BUCHI G
GALLAMINI A
GAVAROTTI P
NOVARINO A
SCALABRINI DR
MAZZA U
PILERI A
SANNAZZARI GL
RESEGOTTI L
Citation: A. Levis et al., PROBABILITY OF CURE IN ELDERLY HODGKINS-DISEASE PATIENTS, Haematologica, 79(1), 1994, pp. 46-54